The spondyloarthropathies (SpAs) are the second-commonest cause of inflammatory arthritis in humans, after rheumatoid arthritis. In adults, there are five conditions within this family of diseases ...

Researchers from Belgium have suggested a potential target for treating spondyloarthropathies: bone morphogenetic proteins (BMPs). This strategy, which specifically targets bone and cartilage ...

Spondyloarthropathies are forms of arthritis that usually strike the bones in your spine and nearby joints. They can cause pain and sometimes damage joints like your backbone, shoulders ...

DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing challenge for patients and rheumatologists alike, according to a speaker at the Congress ...

April 28, 2003 — Anti- Saccharomyces cerevisiae antibodies (ASCA) is the first marker identified with spondyloarthropathies (SpA), according to the results of a study published in the May issue ...

Inhibition of interferon-gamma (IFN- ) is also under study in spondyloarthropathies. Lories points out that although anti-IFN- strategies delay disease onset, they are ineffective once symptoms ...

Enthesitis as a distinguishing feature of PsA PsA is part of a family of arthritis known as spondyloarthropathies. According to the American College of Rheumatology, the term spondyloarthropathy ...

To find out if you simply have IBP or one of these other conditions, which are collectively known as spondyloarthropathies, you and your doctor may need to track your symptoms over an extended ...

Please provide your email address to receive an email when new articles are posted on . While rheumatic diseases like ankylosing spondylitis confound clinicians, tumor necrosis factor inhibitors ...